Concepedia

Hong-liang Qiu

HQ

8

Publications

254

Citations

8

H-Index

2021

Active since

Affiliations

Wuhan University(Current)

Renmin Hospital of Wuhan University

Hong-liang Qiu is an author at Wuhan University specializing in medicine, cell signaling, and pulmonary vascular disease.

Top concepts

Publications per year

2021–2024

8

Publications

8

Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways

Dan Li, Yingying Guo, Xian-feng Cen et al. · Acta Pharmacologica Sinica · 2021 · 92 citations · Full text

, , +8

Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis

Hong-liang Qiu, Sihui Huang, Yuting Liu et al. · Acta Pharmaceutica Sinica B · 2024 · 51 citations · Full text

Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy

Libo Liu, Sihui Huang, Hong-liang Qiu et al. · British Journal of Pharmacology · 2022 · 25 citations · Full text

Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway

Yingying Guo, Dan Li, Xian-feng Cen et al. · Oxidative Medicine and Cellular Longevity · 2022 · 23 citations · Full text

Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis

Tinglv Fu, Guorui Li, Donghang Li et al. · Acta Pharmacologica Sinica · 2024 · 17 citations · Full text

, , +15

Rows per page

1–5 of 8